Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity

British Journal of General Practice

Volumn 63, Issue 607, 2013, Pages

  Lean, Michael ^a   Brosnahan, Naomi ^c   McLoone, Philip ^b   McCombie, Louise ^c   Higgs, Anna Bell ^c   Ross, Hazel ^c   Mackenzie, Mhairi ^b   Grieve, Eleanor ^b   Finer, Nick ^d   Reckless, John ^e   Haslam, David ^f   Sloan, Billy ^b   Morrison, David ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Counterweight Ltd ^*  (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF BATH   (United Kingdom)

^f LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

Author keywords

Healthcare economics and organizations; Morbid obesity; Orlistat; Primary health care

Indexed keywords

TETRAHYDROLIPSTATIN; TRACE ELEMENT;

ADULT; ARTICLE; BODY MASS; DIET THERAPY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HEALTH CARE COST; HUMAN; LOW ENERGY LIQUID DIET; LOW FAT DIET; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIMARY MEDICAL CARE; TREATMENT DURATION; WEIGHT REDUCTION;

ADULT; ANTI-OBESITY AGENTS; DIET, REDUCING; FEASIBILITY STUDIES; FEEDING METHODS; FEMALE; FOOD HABITS; HUMANS; LACTONES; MALE; MICRONUTRIENTS; MIDDLE AGED; OBESITY, MORBID; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 84873157983     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp13X663073     Document Type: Article

References (44)

1. NHS Information Centre. Health Survey for England - 2010: respiratory health. Leeds: The Information Centre, 2011. http://www.ic.nhs.uk/ searchcatalogue?productid=10152&returnid=1685 (accessed 9 Jan 2013).
2. Bromley C, Corbett J, Day J, et al. Scottish Health Survey 2010. Edinburgh: The Scottish Government, 2011. http://www.scotland.gov. uk/News/Releases/2011/09/27102058 (accessed 12 Dec. 2012).
3. Bromley C, Bradshaw P, Given L; Scottish Centre for Social Research. Scottish Health Survey 2008. Edinburgh: The Scottish Government, 2009. http://www.scotland.gov. uk/Publications/2009/09/28102003/0 (accessed 12 Dec. 2012).
4. Scottish Intercollegiate Guidelines Network. Obesity in Scotland: integrating prevention with weight management. SIGN guideline no 8. Edinburgh: Scottish Intercollegiate Guidelines Network, 1996.
5. Torgerson JS, Hauptmann J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomised study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27(1):155-161. (Pubitemid 38196725)
6. Tuomilehto J, Lindstom J, Eriksson, et al; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343-1350. (Pubitemid 32378388)
7. Scottish Intercollegiate Guidelines Network. Management of obesity. SIGN guideline no 115. Edinburgh: Scottish Intercollegiate Guidelines Network, 2010. http://www.sign. ac.uk/pdf/sign115.pdf (accessed 12 Dec. 2012).
8. Lean M E J. Management of obesity and overweight. Medicine 2011;39(1):32-38.
9. Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr 2003;22(5):331-339. (Pubitemid 37254901)
10. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomised controlled trial. JAMA 2008;299(3):316-323. (Pubitemid 351159368)
11. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122(3):248-256.
12. Lean M E J, Powrie JK, Anderson AS, Garthwaite PH. Obesity, weight loss and prognosis in type 2 diabetes. Diab Med 1990;7(3):228-233. (Pubitemid 20104137)
13. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366(17):1567-1576.
14. Lean M E J, Finer N. ABC of obesity. Management: part II - drugs. BMJ 2006;333(7572):794-797.
15. Franz MJ, Van Wormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007;107(10):1755-1767. (Pubitemid 47464109)
16. Astrup A, Carraro R, Finer N, et al on behalf of the NN8022-1807 Investigators. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obesity 2012;36(6):843-854.
17. Lean M E J, Astrup A, Al Hakim M, et al. Sustained weight-loss and acceptable tolerability with the GLP-1 analogue liraglutide in obese non-diabetic adults: a 2-year randomised trial. [Abstract]. Obes 2010;18 (S2) S153.
18. Garrow JS. Energy balance and obesity in man. 2nd edn. Amsterdam: Elsevier, 1978.
19. Bliddal H, Christensen P, Riecke BF, et al. Osteoarthritis - a role for weight maintenance in rheumatology practice: an update. Clin Obes 2011;1(1):50-52.
20. Lin WY, Wu CH, Chu NF, et al. Efficacy and safety of very-low-calorie diet in Taiwanese: a multicentre randomised, controlled trial. Nutrition 2009;25(11-12):1129-1136.
21. Christensen H, Bliddal BF, Riecke AR, et al. Comparison of a low-energy diet and a very low-energy diet in sedentary obese individuals: a pragmatic randomised controlled trial. Clin Obes 2011;1(1):31-40.
22. National Obesity Forum. Position statement on the application of Very Low Energy Diets in achieving weight loss in the management of obesity. Nottingham: National Obesity Forum, 2010. http://www.nationalobesityforum.org.uk/images/ stories/-Final-version-NOF-consensus-statement-VLEDs.pdf (accessed 12 Dec. 2012).
23. Lau S, Caterson ID. Meal replacement products and very low calorie diets in adult obesity. Bull R Coll Pathol 2011;155:172-174.
24. Richelson B, Tonstad S, Rossner S, et al. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomised, placebo-controlled study. Diabetes Care 2007;30(1):27-32. (Pubitemid 46052496)
25. Mathus-Vliegen EMH for the Balance Study Group. Long-term maintenance of weight-loss with sibutramine in a GP setting following a specialist guided verylow-calorie diet: a double-blind, placebo-controlled, parallel group study. Eur J Clin Nutr 2005;59(Suppl 1):S31-S39.
26. Apfelbaum M, Vague P, Ziegler O, et al. Long-term maintenance of weight-loss after a very-low-calorie diet: a randomised blinded trial of the efficacy and tolerability of sibutramine. Am J Med 1999;106(2):179-184. (Pubitemid 29115958)
27. The Counterweight Project Team. The implementation of the Counterweight Programme in Scotland, UK. Fam Pract 2012;29(Suppl 1):i139-i144.
28. The Scottish Government. Scottish Index of Multiple Deprivation. http://www.scotland.gov. uk/Topics/Statistics/SIMD (accessed 12 Dec. 2012).
29. The Counterweight Project Team. Empowering primary care to tackle the obesity epidemic: the Counterweight Programme. Eur J Clin Nutr 2005;59(Suppl 1):S93-S101.
30. Summerbell CD, Watts C, Higgins J P T, Garrow JS. Randomised controlled trial of novel, simple and well supervised weight reducing diets in outpatients. BMJ 1998;317(7171):1487-1489. (Pubitemid 28532605)
31. NHS Choices. The eatwell plate. London: Department of Health, 2011. http://www.nhs.uk/Livewell/Goodfood/Pages/eatwell-plate.aspx (accessed 12 Dec. 2012).
32. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985;39(S1):5-41.
33. The Counterweight Project Team. A new evidence-based model for weight management in primary care: the Counterweight Programme. J Hum Nutr Diet 2004;17(3):191-208.
34. Chief Medical Officers of England, Scotland, Wales and Northern Ireland. Start active, stay active: a report on physical activity from the four home countries' Chief Medical Officers. London: Department of Health, 2011.
35. Personal Social Services Research Unit. Source of unit costs of Health and Social Care 2011. II Community-based health care staff. http://www.pssru.ac. uk/archive/pdf/uc/uc2011/section2.pdf (accessed 9 Jan 2013).
36. British National Formulary. http://www.bnf.org/bnf/index.htm (accessed 12 Dec. 2012).
37. Wycherley TP, Mohr P, Noakes M, et al. Self-reported facilitators of, and impediments to maintenance of healthy lifestyle behaviours following a supervised research-based lifestyle intervention programme in patients with type 2 diabetes. Diabet Med 2012;29(5):632-639.
38. Ackroyd R, Mouiel J, Chevallier JM, Daoud F. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg 2006;16(11):1488-1503. (Pubitemid 44759983)
39. Jolly K, Lewis A, Beach J, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight-loss in obesity: Lighten Up randomised controlled trial. BMJ 2011;343:d6500.
40. The Counterweight Project Team. Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract 2008;58(553):548-554.
41. The Counterweight Project Team. Long-term cost effectiveness of weight management in primary care. Int J Clin Pract 2010;64(6):775-783.
42. Johansson K, Hemmingsson E, Harlid R, et al. Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up study. BMJ 2011;342:d3017.
43. Bischoff SC, Damms-Machado A, Betz C, et al. Multicenter evaluation of an interdisciplinary 52-week weight-loss program for obesity with regard to body weight, comorbidities and quality of life - a prospective study. Int J Obes 2012;36(4):614-624.
44. Lean M E J, Tigbe WW, Briggs, et al. A patient-centred approach to estimate total annual healthcare costs by body mass index in the UK Counterweight programme. Obes Rev 2012. [Epub ahead of print]. http://www.nature.com/doifinder/10.1038/ijo.2012.186 (accessed 9 Jan 2013).